Catalyst Pharmaceuticals (CPRX) Net Equity Issued and Repurchased (2011 - 2024)

Catalyst Pharmaceuticals (CPRX) posted Net Equity Issued and Repurchased of $141.0 million for Q1 2024, up 304.31% on a QoQ basis from $34.9 million in Q1 2015.

Catalyst Pharmaceuticals (CPRX) Net Equity Issued and Repurchased (2011 - 2024) Analysis & Trends

Catalyst Pharmaceuticals' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $141.0 million for Q1 2024.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $141.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $141.0 million (changed N/A YoY) and the FY2024 annual result came in at $141.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was $141.0 million for Q1 2024 at Catalyst Pharmaceuticals, up from $34.9 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $141.0 million in Q1 2024 and bottomed at $141.0 million in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Catalyst Pharmaceuticals 3.85 Bn 3.09 Bn 134.92 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 141.00 Mn
Mar 31, 2024 141.00 Mn
Mar 31, 2015 34.87 Mn
Mar 31, 2015 34.87 Mn
Jun 30, 2011 -271,366.00
Jun 30, 2011 -271,366.00